Bimekizumab
UCB Biopharma
['hidradenitis', 'bimekizumab', 'derm']
#aad2023 - #ucb presented positive results from two phase 3 studies evaluating #bimekizumab's efficacy and safety in treating moderate to severe #hidradenitissuppurativa (hs) in adults. #pharma #pharmaceutical #healthcare #dermatology #aad23 #news #media
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma